Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium homeostasis modulator protein 5 (CALHM5) is a large pore channel protein that assembles as an undecamer in the plasma membrane with four transmembrane helices and an unusually large hydrophobic pore stabilized by tightly bound membrane lipids[1][2][3][4]. It is predicted to participate in monoatomic cation transmembrane transport and ATP export[5]. CALHM5 shares key structural features with other CALHM family members but displays unique pore architecture and gating mechanisms involving lipid interactions. While its precise physiological role remains under study, dysfunction in related CALHM channels is implicated in neuronal pathology and neurodegenerative diseases such as Alzheimer’s disease[4]. The identification of its channel structure offers foundational insight for future functional studies and potential therapeutic targeting. No specific drugs or small molecules targeting CALHM5 are currently known.
Lipid-mediated gating (lipid binding within the channel pore stabilizes and regulates open/closed states) Putative modulation of ATP and ion transport (largely inferred from CALHM family properties)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium homeostasis modulator protein 5 (CALHM5).